DK1085900T3 - Anvendelse af erythropoietin til behandling af primære hæmokromatoser - Google Patents

Anvendelse af erythropoietin til behandling af primære hæmokromatoser

Info

Publication number
DK1085900T3
DK1085900T3 DK99920626T DK99920626T DK1085900T3 DK 1085900 T3 DK1085900 T3 DK 1085900T3 DK 99920626 T DK99920626 T DK 99920626T DK 99920626 T DK99920626 T DK 99920626T DK 1085900 T3 DK1085900 T3 DK 1085900T3
Authority
DK
Denmark
Prior art keywords
erythropoietin
treatment
haemochromatosis
primary
primary haemochromatosis
Prior art date
Application number
DK99920626T
Other languages
English (en)
Inventor
Rene Gottschalk
Paul Lehmann
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998116035 external-priority patent/DE19816035A1/de
Priority claimed from EP98250222A external-priority patent/EP0965349A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1085900T3 publication Critical patent/DK1085900T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99920626T 1998-04-09 1999-04-09 Anvendelse af erythropoietin til behandling af primære hæmokromatoser DK1085900T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998116035 DE19816035A1 (de) 1998-04-09 1998-04-09 Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
EP98250222A EP0965349A1 (de) 1998-06-18 1998-06-18 Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
PCT/EP1999/002422 WO1999052542A1 (en) 1998-04-09 1999-04-09 Use of erythropoietin for the treatment of haemochromatoses

Publications (1)

Publication Number Publication Date
DK1085900T3 true DK1085900T3 (da) 2009-08-10

Family

ID=26045400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920626T DK1085900T3 (da) 1998-04-09 1999-04-09 Anvendelse af erythropoietin til behandling af primære hæmokromatoser

Country Status (10)

Country Link
US (1) US6676947B1 (da)
EP (1) EP1085900B1 (da)
JP (1) JP3930250B2 (da)
AR (1) AR019025A1 (da)
AT (1) ATE433323T1 (da)
AU (1) AU3814599A (da)
DE (1) DE69940971D1 (da)
DK (1) DK1085900T3 (da)
ES (1) ES2326501T3 (da)
WO (1) WO1999052542A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004063927A1 (de) * 2004-01-23 2005-12-15 Epoplus Gmbh Co.Kg Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
KR100701422B1 (ko) * 2004-07-29 2007-03-30 주식회사 하이닉스반도체 케미컬 어택을 방지할 수 있는 반도체소자 및 그 제조 방법
EP1848461A2 (en) 2005-02-16 2007-10-31 Nektar Therapeutics Al, Corporation Conjugates of an epo moiety and a polymer
CN101939443B (zh) 2008-02-08 2014-01-29 Ambrx公司 经修饰瘦素多肽和其用途
PT2318029T (pt) 2008-07-23 2018-01-10 Ambrx Inc Polipéptidos de g-csf bovino modificados e suas utilizações
EP2342223B1 (en) 2008-09-26 2017-04-26 Ambrx, Inc. Modified animal erythropoietin polypeptides and their uses
EP2316334A1 (en) 2009-10-22 2011-05-04 Fresenius Medical Care Deutschland GmbH A method for assessing a patient's fluid status and /or sensitivity to fluid removal, controller, and devices
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US5013718A (en) 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO
DE3729863A1 (de) 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
AU723740B2 (en) * 1995-06-06 2000-09-07 Howmedica Inc. Biocompatible hydroxyapatite formulations and uses therefor
TW586933B (en) * 1996-06-20 2004-05-11 Chugai Pharmaceutical Co Ltd Compositions for treating liver-complaints using EPO
FI964138A (fi) 1996-10-15 1998-04-16 Nokia Telecommunications Oy Kanavanvarausmenetelmä ja radiojärjestelmä

Also Published As

Publication number Publication date
AR019025A1 (es) 2001-12-26
JP2002511418A (ja) 2002-04-16
AU3814599A (en) 1999-11-01
US6676947B1 (en) 2004-01-13
EP1085900B1 (en) 2009-06-10
EP1085900A1 (en) 2001-03-28
ATE433323T1 (de) 2009-06-15
WO1999052542A1 (en) 1999-10-21
JP3930250B2 (ja) 2007-06-13
DE69940971D1 (de) 2009-07-23
ES2326501T3 (es) 2009-10-13

Similar Documents

Publication Publication Date Title
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
NO2009003I1 (no) Etravirin
DE69936997D1 (de) Paletteneinrichtung
DK0937016T3 (da) Behandling af kulbrintegas
DE69938817D1 (de) Erstellungsverfahren
DK1021194T3 (da) Ny forbedret formulering til behandling af osteoporose
NO992430D0 (no) R°rkobling
DK1094733T3 (da) Fremgangsmåde til fremstilling af børstehårsvarer og børstehårsvarer fremstillet herefter
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
NO992198D0 (no) R°rledningspigg
DK0923978T3 (da) Fremgangsmåde til behandling af röggas
DK1206436T3 (da) Retinoider til behandling af emfysem
DK199800837A (da) Anlæg til behandling af emner
DK0930091T3 (da) Fremgangsmåde til behandling af röggasser
FI981247A (fi) Muuntaja
PT1042414E (pt) Revestimentos anti-deposicao
DE19980175D2 (de) Farbdose
DK1085900T3 (da) Anvendelse af erythropoietin til behandling af primære hæmokromatoser
DK1702623T3 (da) Anvendelse af interferon-gamma til behandling af hjertehypertrofi
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DE69937136D1 (de) Lackiervorrichtung
NO20005023D0 (no) FremgangsmÕter for Õ hemme MRP1
DK0862939T3 (da) Fremgangsmåde til behandling af röggas
FI981486A0 (fi) Kanavanvaihtomenetelmä
NO20005041D0 (no) FremgangsmÕte for Õ inhibere MRP1